BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/22/2024 4:25:08 AM | Browse: 176 | Download: 509
 |
Received |
|
2023-11-03 10:57 |
|
Peer-Review Started |
|
2023-11-03 10:58 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-12-05 23:58 |
|
Revised |
|
2023-12-09 09:07 |
|
Second Decision |
|
2023-12-26 03:24 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-12-26 07:13 |
|
Articles in Press |
|
2023-12-26 07:13 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-01-16 10:34 |
|
Publish the Manuscript Online |
|
2024-01-22 04:25 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Reproductive Biology |
| Manuscript Type |
Editorial |
| Article Title |
Application of mesenchymal stem cell therapy for premature ovarian insufficiency: Recent advances from mechanisms to therapeutics
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Hang-Qi Hu, Xi-Yan Xin, Yu-Tian Zhu, Rui-Wen Fan, Hao-Lin Zhang, Yang Ye and Dong Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Cohort Construction Project of Peking University Third Hospital |
BYSYDL2022013 |
| Clinical Key Project of Peking University Third Hospital |
BYSY2023049 |
| Special Grant for Capital Health Research and Development |
2022-2-4097 |
| Funding from State Key Laboratory of Female Fertility Promotion, Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital |
BYSYSZKF2023027 |
|
| Corresponding Author |
Yang Ye, PhD, Assistant Professor, Department of Traditional Chinese Medicine, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing 100191, China. yeyang89@bjmu.edu.cn |
| Key Words |
Mesenchymal stem cell therapy; Mechanism; Premature ovarian insufficiency; Therapeutic; Women |
| Core Tip |
Premature ovarian insufficiency (POI) is an increasing cause of infertility globally, particularly among younger women, with profound effects on reproductive function and health. With limited treatment options and unsatisfactory results, the use of mesenchymal stem cell (MSC) therapies offers promising transformative approaches to restore ovarian function and enhance reproductive health in women. This article provides a concise overview and evidence of the potential benefits of MSC therapy for POI. |
| Publish Date |
2024-01-22 04:25 |
| Citation |
Hu HQ, Xin XY, Zhu YT, Fan RW, Zhang HL, Ye Y, Li D. Application of mesenchymal stem cell therapy for premature ovarian insufficiency: Recent advances from mechanisms to therapeutics. World J Stem Cells 2024; 16(1): 1-6 |
| URL |
https://www.wjgnet.com/1948-0210/full/v16/i1/1.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v16.i1.1 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
